InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Smith Scott Thomas. Officer active across 1 company, notably Ascendis Pharma A/S. Cumulatively, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €67k. Activity tracked since 29 May 2026. The latest transaction was filed on 2 June 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations